A Prospective Randomized Pilot Study Examining the Role and Effectiveness of Conversion to Sirolimus Versus CNI Reduction in Renal Transplant Patients With Prostate Cancer.
Withdrawn prior to enrolment
Phase of Trial: Phase II/III
Latest Information Update: 06 Mar 2012
At a glance
- Drugs Sirolimus (Primary) ; Ciclosporin; Tacrolimus
- Indications Prostate cancer
- Focus Therapeutic Use
- 27 Jul 2011 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 23 Jun 2009 New trial record